Kierzkowska B, Stańczyk J, Wiectawska B, Rózalski M, Boncler M, Chrul S, Watala C
Clinic of Paediatric Cardiology, Institute of Paediatrics, Medical University of Lódz, ul. Narutowicza 96, 90-141, Lódz, Poland.
Int J Cardiol. 2001 Jun;79(1):49-59. doi: 10.1016/s0167-5273(01)00404-1.
Abnormal platelet function has been hypothesised to play a role in the haemostatic abnormalities in cyanotic congenital heart disease (CCHD) patients. Using whole blood flow cytometry we found that platelets from cyanotic patients were hyperreactive and we related such hyperreactivity directly to young age, unoperated state, high haematocrit, reduced saturation with oxygen and low platelet count. Circulating platelets from CCHD children showed significantly enhanced P-selectin expression (P<0.004) and remained more reactive to 0.2 IU/ml thrombin, 1-8 microM TRAP and 2-4 microM ADP (P<0.04), especially in younger (0-3-year-olds) patients. Such a platelet 'priming' largely concerned CCHD children who were not subjected to modified Blalock-Taussig shunts in the past (non-MBTS). Only non-MBTS cyanotic children, but not MBTS-operated patients, showed significantly higher platelet reactivity compared to controls in response to ADP or 1 microM TRAP with respect to P-selectin expression (p<0.05) and in response to all examined agonists with respect to GPIb expression (P<0.045). The enhanced P-selection expression in MBTS-operated CCHD children and reduced GPIb expression in non-MBTS patients, especially in younger patients, were positively associated with the occurrence of the polymorphic variant Pl(A2) of platelet membrane glycoprotein IIIa gene. Altered blood morphology parameters (elevated RBC, Hb, Hct and MCHC, for all P<0.0005) in CCHD children correlated with the enhanced degranulation of circulating blood platelets and their hyperreactivity in response to some agonists (P<0.05). Overall, our data encourage the reasoning that circulating platelets are remarkably hyperreactive in non-MBTS cyanotic children, which are at higher risk to often encounter platelets activation in circulation. It seems unlikely that the apparently unchanged platelet reactivity in MBTS-operated children is due to the advantageous effects of the shunt, since these patients showed neither altered haematological parameters nor improved oxygen carrying capacity. Otherwise, it may rather result from more frequent episodes of platelet degranulation and preactivation in the past, and/or post-operative enhanced platelet consumption.
异常的血小板功能被认为在青紫型先天性心脏病(CCHD)患者的止血异常中起作用。通过全血流式细胞术,我们发现青紫型患者的血小板反应性过高,并且我们将这种高反应性直接与年轻、未手术状态、高血细胞比容、氧饱和度降低和低血小板计数相关联。CCHD儿童的循环血小板显示P-选择素表达显著增强(P<0.004),并且对0.2 IU/ml凝血酶、1-8 microM TRAP和2-4 microM ADP的反应仍然更强(P<0.04),尤其是在较年轻(0-3岁)的患者中。这种血小板“预激活”主要涉及过去未接受改良Blalock-Taussig分流术(非MBTS)的CCHD儿童。仅非MBTS青紫型儿童,而非接受MBTS手术的患者,与对照组相比,在对ADP或1 microM TRAP的反应中,就P-选择素表达而言(p<0.05),以及在对所有检测的激动剂的反应中,就糖蛋白Ib(GPIb)表达而言(P<0.045),显示出显著更高的血小板反应性。接受MBTS手术的CCHD儿童中P-选择素表达增强,而非MBTS患者中GPIb表达降低,尤其是在较年轻患者中,与血小板膜糖蛋白IIIa基因的多态性变体Pl(A2)的发生呈正相关。CCHD儿童血液形态学参数的改变(红细胞、血红蛋白、血细胞比容和平均红细胞血红蛋白浓度升高,所有P<0.0005)与循环血小板脱颗粒增强及其对某些激动剂的高反应性相关(P<0.05)。总体而言,我们的数据支持这样的推断,即非MBTS青紫型儿童的循环血小板反应性显著过高,这些儿童在循环中经常遇到血小板激活的风险更高。接受MBTS手术的儿童中血小板反应性明显未改变,似乎不太可能是由于分流的有利影响,因为这些患者既没有血液学参数的改变,也没有改善的携氧能力。否则,这可能更多是由于过去更频繁的血小板脱颗粒和预激活事件,和/或术后血小板消耗增加所致。